Security Snapshot

Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) Institutional Ownership

CUSIP: 929033207

13F Institutional Holders and Ownership History from Q3 2025 to Q1 2026

Latest Period

Q4 2025

Institutions Reporting

53

Shares (Excl. Options)

25,530,116

Price

$13.08

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place.

Create free account to save this page Review latest holder period
Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
VOR on Nasdaq
Shares outstanding
43,408,727
Price per share
$17.85
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
25,530,116
Total reported value
$331,798,548
% of total 13F portfolios
0%
Share change
+20,825,485
Value change
+$261,399,708
Number of holders
53
Price from insider filings
$17.85
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Sponsored

Quick Takeaways

  • VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share is tracked under CUSIP 929033207.
  • 53 institutions reported positions in Q4 2025.
  • 10 significant owners is listed from Schedule 13D/13G reporting.

What Changed

  • Holder count moved from 53 to 2 between Q4 2025 and Q1 2026.
  • Reported value moved from $331,798,548 to $7,332.

Why This Matters

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Source Evidence

Source: SEC Form 13F

Latest holder context comes from 53 institutions filings for Q4 2025.

Open SEC Evidence

Investment Quick Answers

What is CUSIP 929033207?
CUSIP 929033207 identifies VOR - Vor Biopharma Inc. - Common Stock, $0.0001 par value per share in SEC 13F datasets.

Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.

Significant Owners of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ForGrowth III PA B.V. 10% 0% $81,492,203 +$25,772,203 10,237,714 +46% ForGrowth III PA B.V. 18 Dec 2025
RA CAPITAL MANAGEMENT, L.P. 14% +41% $43,075,707 +$24,407,302 5,411,521 +131% RA Capital Management, L.P. 18 Dec 2025
Verve Capital Ltd 9.9% 0% $58,273,612 +$47,958,533 4,297,464 +465% Verve Capital Limited 31 Dec 2025
FMR LLC 6.5% -42% $37,185,222 +$25,579,283 2,526,170 +220% FMR LLC 31 Dec 2025
Frazier Life Sciences Public Fund, L.P. 5.8% $17,973,688 2,258,001 Frazier Life Sciences Public Fund, L.P. 18 Dec 2025
Venrock Healthcare Capital Partners III, L.P. 9.9% 0% $30,049,977 +$19,734,899 2,216,075 +191% Venrock Healthcare Capital Partners III, L.P. 31 Dec 2025
Paradigm Biocapital Advisors LP 4.5% -46% $23,730,000 1,750,000 0% Paradigm BioCapital Advisors LP 31 Dec 2025
GREAT POINT PARTNERS LLC 3.3% -39% $18,578,651 +$1,839,021 1,370,107 +11% Great Point Partners, LLC 31 Dec 2025
Reprogrammed Interchange LLC 18% $48,045,191 1,204,442 Reprogrammed Interchange LLC 15 Oct 2025
Qiming Venture Partners VIII-HC, L.P. 2.8% -53% $14,777,241 +$8,047,792 1,089,767 +120% Qiming Venture Partners VIII-HC, L.P. 31 Dec 2025

As of 31 Dec 2025, 53 institutional investors reported holding 25,530,116 shares of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR). This represents 59% of the company’s total 43,408,727 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) together control 58% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
RA CAPITAL MANAGEMENT, L.P. 12% 5,404,998 +173% 0.73% $70,697,374
FCPM III SERVICES B.V. 8.3% 3,617,354 +853% 6.2% $47,314,990
Frazier Life Sciences Management, L.P. 5.9% 2,543,939 0.89% $33,274,722
FMR LLC 5.8% 2,526,170 +968% 0% $33,042,304
VR ADVISER, LLC 4.5% 1,943,766 +289% 1.3% $25,424,459
Paradigm Biocapital Advisors LP 4% 1,750,000 0.61% $22,890,000
GREAT POINT PARTNERS LLC 3.2% 1,370,107 5.8% $17,921,000
NEXTBio Capital Management LP 2.3% 999,967 0% 7.7% $13,079,568
Caligan Partners LP 2.1% 925,067 0.91% $9,962,972
VANGUARD GROUP INC 1.8% 770,250 +632% 0% $10,074,870
BlackRock, Inc. 1.1% 465,636 +1248% 0% $6,090,520
CITADEL ADVISORS LLC 1% 433,894 +7531% 0% $5,675,334
SPHERA FUNDS MANAGEMENT LTD. 0.95% 410,417 1.1% $5,368,254
Laurion Capital Management LP 0.73% 317,243 0.28% $4,149,538
UBS Group AG 0.67% 292,118 +285% 0% $3,820,904
FINDELL CAPITAL MANAGEMENT LLC 0.53% 231,000 1% $3,021,480
MILLENNIUM MANAGEMENT LLC 0.52% 224,534 +807% 0% $2,936,905
GEODE CAPITAL MANAGEMENT, LLC 0.43% 185,808 +578% 0% $2,431,650
TUDOR INVESTMENT CORP ET AL 0.39% 167,673 0.01% $2,193,163
AMERIPRISE FINANCIAL INC 0.38% 163,061 0% $2,132,838
GOLDMAN SACHS GROUP INC 0.34% 145,640 +823% 0% $1,904,971
Logos Global Management LP 0.23% 100,000 0.09% $1,308,000
JANE STREET GROUP, LLC 0.21% 91,810 +448% 0% $1,200,875
STATE STREET CORP 0.21% 91,053 +906% 0% $1,190,973
JOHNSON & JOHNSON 0.12% 53,732 0.13% $702,815

Institutional Holders of Vor Biopharma Inc. - Common Stock, $0.0001 par value per share (VOR) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 411 $7,332 +$1,445 $17.84 2
2025 Q4 25,530,116 $331,798,548 +$261,399,708 $13.08 53
2025 Q3 3,710,338 $180,767,786 +$180,382,226 $48.72 35

Sponsored